[1]The National Clinical Research Center for Mental Disorders & Beijing Key Laboratory of Mental Disorders & Beijing Institutefor Brain Disorders Center of Schizophrenia;
Beijing Anding Hospital;
Capital Medical University;
Beijing 100088;
China;
[1]The National Clinical Research Center for Mental Disorders & Beijing Key Laboratory of Mental Disorders & Beijing Institutefor Brain Disorders Center of Schizophrenia;
Beijing Anding Hospital;
Capital Medical University;
Beijing 100088;
China;
[1]The National Clinical Research Center for Mental Disorders & Beijing Key Laboratory of Mental Disorders & Beijing Institutefor Brain Disorders Center of Schizophrenia;
Beijing Anding Hospital;
Capital Medical University;
Beijing 100088;
China;
[1]The National Clinical Research Center for Mental Disorders & Beijing Key Laboratory of Mental Disorders & Beijing Institutefor Brain Disorders Center of Schizophrenia;
Beijing Anding Hospital;
Capital Medical University;
Beijing 100088;
China;
[2]Department of Psychiatry and Behavioral Sciences;
Emory University School of Medicine;
Atlanta 30322;
USA;
[3]Mental Health Service Line;
Atlanta VA Medical Center;
Decatur 30033;
USA;
[1]The National Clinical Research Center for Mental Disorders & Beijing Key Laboratory of Mental Disorders & Beijing Institutefor Brain Disorders Center of Schizophrenia;
Beijing Anding Hospital;
Capital Medical University;
Beijing 100088;
China;
prepulse inhibition(PPI); antipsychotic-na-ve; first-episode schizophrenia; patients; meta-analysis;